Explore what FDA approval of elamipretide means for ultra-rare disease drug development and the outlook for future biotech ...

Consider this your final warning to grab the second Founders Pack, which contains various pieces of equipment and visual ...

Slow Horses will return on Wednesday (September 24) and will be released weekly. The first two episodes are set to be ...

Mixed-use property spaces that combine residential, commercial, and sometimes even industrial functions are becoming ...

Uber has called on the Government to create a national, real-time database of all currently licensed private hire vehicle ...

Newly surfaced DHS documents, including emails, training materials, policy directives, and quarterly reports, reveal just how ...

NEW YORK, NY / ACCESS Newswire / September 11, 2025 / From the start, recycling was pitched as the low-cost, high-impact fix ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), presents new data for Ocrevus ® (ocrelizumab) and the investigational Bruton’s tyrosine kinase (BTK) inhibitor fenebrutinib at the ...

State-owned enterprises (SOEs) across emerging economies face a fundamental challenge: how to leverage their procurement power to drive economic transformation while maintaining operational efficiency ...

Here's our review of Sync, a popular online storage service. We delve deeper into its pros and cons, prices, features, apps, ...

We’ve seen it happen - even the most carefully planned M&A deals can be derailed as the finish line comes into sight. Seasoned investors and serial entrepreneurs alike can be caught off guard by a ...

Between fragmented hospital records and regulatory uncertainty under the DPDP Act, India’s healthtech start-ups face a severe ...